Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ocular toxicology.

G D Novack1

  • 1PharmaLogic Development, Inc., Irvine, California, USA.

Current Opinion in Ophthalmology
|November 4, 1994
PubMed
Summary
This summary is machine-generated.

Systemic medications can cause various ocular toxicities, including glaucoma and cataracts. Physicians must balance drug efficacy against potential eye damage when making treatment decisions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ophthalmic drug delivery: development and regulatory considerations.

Clinical pharmacology and therapeutics·2009
Same author

Commercially available ocular hypotensive products: preservative concentration, stability, storage, and in-life utilization.

Journal of glaucoma·2001
Same author

Ocular safety of INS365 ophthalmic solution: a P2Y(2) agonist in healthy subjects.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2001
Same author

Submission of data sets to journals: what's the real issue?

Archives of ophthalmology (Chicago, Ill. : 1960)·2000
Same author

Update on regulatory review intervals for ophthalmic new drug applications at the United States Food and Drug Administration.

American journal of ophthalmology·2000
Same author

Financing new drug development in ophthalmology.

Journal of glaucoma·2000

Area of Science:

  • Ophthalmology
  • Toxicology
  • Pharmacology

Background:

  • Systemic xenobiotics can induce a range of adverse ocular effects.
  • Understanding these toxicities is crucial for patient safety and effective treatment.

Purpose of the Study:

  • To review recent literature on ocular toxicities caused by systemically administered drugs.
  • To highlight specific drug-induced ocular conditions and potential management strategies.

Main Methods:

  • Literature review of recent articles on ocular toxicology.
  • Focus on undesirable effects on the eye from systemically used xenobiotics.

Main Results:

  • Identified numerous drug-induced ocular toxicities: corticosteroid-induced glaucoma/cataracts, chloroquine retinopathy, chemotherapy-related oculopathy, ketoconazole papilledema, and others.

Related Experiment Videos

  • Discussed hormonal influences on diabetic retinopathy, effects of clonidine, pentoxifylline, and nicotine on ocular blood flow.
  • Reviewed potential mydriatic medication reduction and sulfonamide-induced myopia theories.

    • Conclusions:

    • No medication offers absolute efficacy or safety.
    • Physicians must carefully evaluate the therapeutic index (efficacy vs. toxicity) for each patient.
    • Informed clinical judgment is essential for balancing treatment benefits against ocular risks.